S231: PRIMARY MEDIASTINAL B-CELL LYMPHOMA HAVE A SUPERIOR OUTCOME COMPARED TO DIFFUSE LARGE-B-CELL LYMPHOMA TREATED WITH AXICABTAGENE CILOLEUCEL IN THE CART-SIE REAL LIFE ITALIAN STUDY

類似資料

• Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing
  著者:: Xuefeng Wang, 等
  出版事項: (2025-07-01)
• P1111: COMPARATIVE EFFICACY AND SAFETY OF TISAGENLECLEUCEL AND AXICABTAGENE CILOLEUCEL IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA
  著者:: M. Dickinson, 等
  出版事項: (2022-06-01)
• Patterns of immune recovery after axicabtagene ciloleucel for aggressive B‐cell lymphoma
  著者:: André Airosa Pardal, 等
  出版事項: (2025-10-01)
• P1398: AXICABTAGENE CILOLEUCEL VERSUS TISAGENLECLEUCEL CAR-T CELLS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
  著者:: Nico Gagelmann, 等
  出版事項: (2023-08-01)
• TAFRO-like syndrome associated with long-term CAR-T cell persistence after axicabtagene ciloleucel therapy
  著者:: Pedro José Mirete, 等
  出版事項: (2026-07-01)